title: [The rocky road to more acceptable antirheumatic drugs].
authors.affiliation: Klaus Miehlke-Klinik, Rheumatologie, Wiesbaden. wbolten@em.uni-frankfurt.de
authors.forename: W W
authors.initials: WW
authors.lastname: Bolten
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000191:economics; D001161:Arteriosclerosis / Q000517:prevention & control; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000191:economics / Q000592:standards*; D041981:Gastrointestinal Tract / Q000187:drug effects; D006801:Humans; D054328:Proton Pump Inhibitors; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D054328:Proton Pump Inhibitors